SCHEMBL3168246

SCHEMBL3168246

CC(=O)NCCNc1cc(NCCNC(=O)C=Cc2ccsc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.40
PIM2 Q9P1W9 1/20 0.39
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
CYP1A2 P05177 2/20 0.39
PYGL P06737 1/20 0.38
MAPT P10636 1/20 0.37
NLRP3 Q96P20 1/20 0.37
ADORA2A P29274 1/20 0.37
LTA4H P09960 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3168238 1.00 ADORA3 (0.40) ADORA3PIM2TAS1R3TAS1R1CYP1A2
SCHEMBL3171308 0.91 PIM2 (0.46) ADORA3PIM2TAS1R3TAS1R1CYP1A2
SCHEMBL3171320 0.91 PIM2 (0.46) ADORA3PIM2TAS1R3TAS1R1CYP1A2
SCHEMBL3170642 0.87 KMT2A (0.49) ADORA3PIM2CYP1A2MAPTNLRP3
SCHEMBL3170630 0.87 KMT2A (0.49) ADORA3PIM2CYP1A2MAPTNLRP3
SCHEMBL3163351 0.84 SMN1; SMN2 (0.51) ADORA3PIM2CYP1A2PYGLMAPT
SCHEMBL3163340 0.84 SMN1; SMN2 (0.51) ADORA3PIM2CYP1A2PYGLMAPT
SCHEMBL3171885 0.83 MAPT (0.48) ADORA3MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL3171874 0.83 MAPT (0.48) ADORA3MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL3173846 0.83 KDM4E (0.40) ADORA3MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed